Beam Therapeutics Inc. - Common Stock (BEAM)

CUSIP: 07373V105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
100,548,635
Total 13F shares
27,707,853
Share change
+941,485
Total reported value
$775,554,484
Price per share
$28.00
Number of holders
70
Value change
+$34,103,632
Number of buys
44
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 07373V105?
CUSIP 07373V105 identifies BEAM - Beam Therapeutics Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BEAM - Beam Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
6.9%
6,971,912
$125,494,000 31 Mar 2020
13F
Redmile Group, LLC
13F
Company
3.3%
3,359,258
$60,467,000 31 Mar 2020
13F
Temasek Holdings (Private) Ltd
13F
Company
3.3%
3,354,641
$60,384,000 31 Mar 2020
13F
HHLR ADVISORS, LTD.
13F
Company
3%
2,966,403
$53,395,000 31 Mar 2020
13F
FIL Ltd
13F
Company
1.6%
1,626,779
$29,282,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
1.2%
1,254,005
$22,571,000 31 Mar 2020
13F
HSG Holding Ltd
13F
Company
1.1%
1,120,535
$20,170,000 31 Mar 2020
13F
Cormorant Asset Management, LP
13F
Company
0.79%
796,429
$14,336,000 31 Mar 2020
13F
Alphabet Inc.
13F
Company
0.66%
663,691
$11,946,000 31 Mar 2020
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
0.5%
500,000
$9,000,000 31 Mar 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.45%
456,447
$8,216,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.36%
362,958
$6,534,000 31 Mar 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.33%
332,000
$5,976,000 31 Mar 2020
13F
Omega Fund Management, LLC
13F
Company
0.3%
302,821
$5,451,000 31 Mar 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.3%
300,509
$5,409,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.26%
264,871
$4,768,000 31 Mar 2020
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.26%
264,681
$4,764,000 31 Mar 2020
13F
Marshall Wace North America L.P.
13F
Company
0.25%
251,762
$4,532,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.21%
213,105
$3,836,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0.19%
189,381
$3,409,000 31 Mar 2020
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.17%
170,164
$3,063,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.13%
131,026
$2,358,000 31 Mar 2020
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.12%
122,123
$2,198,000 31 Mar 2020
13F
Granahan Investment Management, LLC
13F
Company
0.1%
98,276
$1,769,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
0.09%
93,942
$1,691,000 31 Mar 2020
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.09%
89,813
$1,617,000 31 Mar 2020
13F
DC Investments Management, LLC
13F
Company
0.09%
88,100
$1,586,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.09%
86,299
$1,553,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
71,566
$1,288,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.05%
46,093
$830,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
40,186
$723,000 31 Mar 2020
13F
Ensign Peak Advisors, Inc
13F
Company
0.03%
34,606
$623,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
26,005
$469,000 31 Mar 2020
13F
Laurion Capital Management LP
13F
Company
0.02%
25,000
$450,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.02%
22,421
$403,000 31 Mar 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.02%
21,000
$378,000 31 Mar 2020
13F
NORGES BANK
13F
Company
0.02%
20,000
$360,000 31 Mar 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.02%
19,000
$342,000 31 Mar 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
18,669
$336,000 31 Mar 2020
13F
BRANDYWINE MANAGERS, LLC
13F
Company
0.02%
15,300
$275,000 31 Mar 2020
13F
Zimmer Partners, LP
13F
Company
0.01%
12,500
$225,000 31 Mar 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
11,693
$210,000 31 Mar 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
11,100
$200,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
7,903
$142,000 31 Mar 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
7,271
$131,000 31 Mar 2020
13F
MetLife Investment Management, LLC
13F
Company
0.01%
6,621
$119,178 31 Mar 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
6,600
$119,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
6,522
$117,000 31 Mar 2020
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0%
4,682
$84,276 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
0%
4,400
$79,000 31 Mar 2020
13F

Institutional Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q2 2020

As of 30 Jun 2020, Beam Therapeutics Inc. - Common Stock (BEAM) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,707,853 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, Temasek Holdings (Private) Ltd, HILLHOUSE CAPITAL ADVISORS, LTD., FIL Ltd, BlackRock Inc., VANGUARD GROUP INC, SC CHINA HOLDING Ltd, Cormorant Asset Management, LP, and Alphabet Inc.. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
60
Q2 2020 holders
70
Holder diff
10
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .